id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-324981-teywszlm	Eccles, Ron	Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold	2010-08-10		.txt	text/plain	5472	295	54	title: Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold METHODS: In a randomized, double-blind, placebo-controlled exploratory trial, 35 human subjects suffering from early symptoms of common cold received Iota-Carrageenan (0.12%) in a saline solution three times daily for 4 days, compared to placebo. The presented exploratory study was designed to determine the magnitude of any effect of Iota-Carrageenan nasal spray on the severity of common cold symptoms relative to placebo treatment. The current study was designed as a single centre, randomised, double-blind, parallel group, placebo-controlled comparative survey in subjects with early symptoms of common cold to assess the efficacy of a 0.12% Iota-Carrageenan nasal spray in the early treatment of natural colds. The results of this study indicate that the Iota Carrageenan nasal spray is a safe and effective treatment when taken within 48 hours of development of common cold symptoms.	./cache/cord-324981-teywszlm.txt	./txt/cord-324981-teywszlm.txt